4th Quarter - Report

CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Implementation of Tax Cuts and Jobs Act (P.L.115-97). FY2022 Budget Resolution (S.Con.Res.14)/Budget Reconciliation (H.R.5376); issues related to international taxation.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th), S.Con.Res. 14 (117th)

Copyright/Patent/Trademark CPT

Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, and education around COVID-19 therapies. S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 909 (117th), S. 920 (117th), S. 908 (117th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Resolution (S.Con.Res.14)/Budget Reconciliation (H.R.5376).

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1868 (117th), H.R. 3 (117th), H.R. 5376 (117th), S.Con.Res. 14 (117th), H.R. 1319 (117th)

Budget/Appropriations BUD

FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.4356/S.2599); H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2022 Consolidated Appropriations Act (H.R.4502); all bio-pharmaceutical related provisions.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4356 (117th), H.R. 4502 (117th), H.R. 1319 (117th), H.R. 133 (117th), H.R. 748 (117th), S. 2599 (117th)

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1260 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.